tirzepatide studies 2025 Impact of 1-Year Use on Glycemic and Metabolic Profile in Overweight to Obese People with Type 1 Diabetes: A Systematic Review and Meta-Analysis Tirzepatide vs Semaglutide: 2025 NEJM
Description
The company also advertises a "365-Day Money-Back Guarantee" described as a "Weight Loss Warranty." According to the company's website, terms and conditions apply to this guarantee
They review your health history and tailor the tirzepatide dose for you
NIH / NCBI Review: PubMed Clinical Data: Tirzepatide (NEJM): Disclaimer: GLP-1 medications, including Mounjaro (Tirzepatide) and Semaglutide, require a medical evaluation and are not suitable for everyone
Tirzepatide's extrapancreatic actions also contribute importantly to its cardiometabolic profile
It also slows down the movement of food from the stomach, making people feel fuller for longer
Yes this is a common and medically straightforward transition under provider supervision
